Tone Skeie-Jensen
Publications by Year
Research Areas
Endometrial and Cervical Cancer Treatments, Colorectal Cancer Surgical Treatments, Cervical Cancer and HPV Research, Ovarian cancer diagnosis and treatment, Uterine Myomas and Treatments
Most-Cited Works
- → Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)(2017)52 cited
- → A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer(2012)42 cited
- → Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma(2012)40 cited
- → Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas(2017)26 cited
- → Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma(2017)15 cited
- → Pelvic exenteration for vulvar cancer: Postoperative morbidity and oncologic outcome – A single center retrospective analysis(2023)11 cited
- → Pegylated liposomal doxorubicin and carboplatin (C-PLD) versus paclitaxel and carboplatin (C-P) in platinum-sensitive ovarian cancer (OC) patients (pts): Treatment at recurrence and overall survival (OS) final analysis from CALYPSO phase III GCIG trial.(2011)10 cited
- → Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma(2023)3 cited
- → Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma (1129)(2023)2 cited
- → Stathmin is an Independent Prognostic Marker of Poor Outcome in Uterine Leiomyosarcoma(2024)1 cited